Efficacy and safety of artemisinin-based combination therapy, and molecular markers for artemisinin and piperaquine resistance in Mainland Tanzania
MA Kakolwa, MK Mahende, DS Ishengoma… - Malaria journal, 2018 - Springer
Background Artemisinin-based combination therapy (ACT) is the first-line anti-malarial
treatment of uncomplicated malaria in most malaria endemic countries, including Tanzania. …
treatment of uncomplicated malaria in most malaria endemic countries, including Tanzania. …
Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated malaria and prevalence of Pfk13 and Pfmdr1 polymorphisms after a decade of …
…, B Ngasala, AM Kabanywanyi, MK Mahende… - Malaria journal, 2019 - Springer
Background The World Health Organization recommends regular therapeutic efficacy studies
(TES) to monitor the performance of first and second-line anti-malarials. In 2016, efficacy …
(TES) to monitor the performance of first and second-line anti-malarials. In 2016, efficacy …
Describing the current status of Plasmodium falciparum population structure and drug resistance within mainland Tanzania using molecular inversion probes
…, R Mandike, AM Kabanywanyi, MK Mahende… - Molecular …, 2021 - Wiley Online Library
High‐throughput Plasmodium genomic data is increasingly useful in assessing prevalence
of clinically important mutations and malaria transmission patterns. Understanding parasite …
of clinically important mutations and malaria transmission patterns. Understanding parasite …
Effectiveness of the innovative 1, 7-malaria reactive community-based testing and response (1, 7-mRCTR) approach on malaria burden reduction in Southeastern …
…, K Lin, E Tambo, SF Rumisha, S Mkude, MK Mahende… - Malaria journal, 2020 - Springer
Background In 2015, a China-UK-Tanzania tripartite pilot project was implemented in
southeastern Tanzania to explore a new model for reducing malaria burden and possibly scaling-…
southeastern Tanzania to explore a new model for reducing malaria burden and possibly scaling-…
Trends of Plasmodium falciparum molecular markers associated with resistance to artemisinins and reduced susceptibility to lumefantrine in Mainland Tanzania from …
…, M Chiduo, T Makene, AM Kabanywanyi, MK Mahende… - Malaria Journal, 2024 - Springer
Background Therapeutic efficacy studies (TESs) and detection of molecular markers of drug
resistance are recommended by the World Health Organization (WHO) to monitor the …
resistance are recommended by the World Health Organization (WHO) to monitor the …
Pilot deployment of a community health care worker in distributing and offering the COVID-19 AgRDT in Tanzania
…, G Mwangoka, AM Ali, A Mkopi, MK Mahende… - Scientific Reports, 2024 - nature.com
A pilot implementation of the rapid diagnostic test program was performed to collect evidence
of the feasibility, acceptability, and uptake of the COVID-19 AgRDT in Tanzania. We …
of the feasibility, acceptability, and uptake of the COVID-19 AgRDT in Tanzania. We …
Multi-country evaluation of safety of dihydroartemisinin/piperaquine post-licensure in African public hospitals with electrocardiograms
AM Kabanywanyi, R Baiden, AM Ali, MK Mahende… - PLoS …, 2016 - journals.plos.org
The antimalarial drug piperaquine is associated with delayed ventricular depolarization,
causing prolonged QT interval (time taken for ventricular de-polarisation and re-polarisation). …
causing prolonged QT interval (time taken for ventricular de-polarisation and re-polarisation). …
Comparative palatability of orally disintegrating tablets (ODTs) of praziquantel (L-PZQ and Rac-PZQ) versus current PZQ tablet in African children: a randomized …
MK Mahende, E Huber, E Kourany-Lefoll… - PLoS Neglected …, 2021 - journals.plos.org
Background Praziquantel (PZQ) is currently the only recommended drug for infection and
disease caused by the schistosome species that infects humans; however, the current tablet …
disease caused by the schistosome species that infects humans; however, the current tablet …
Microsatellites reveal high polymorphism and high potential for use in anti-malarial efficacy studies in areas with different transmission intensities in mainland …
…, B Ngasala, AM Kabanywanyi, MK Mahende… - Malaria Journal, 2024 - Springer
Background Tanzania is currently implementing therapeutic efficacy studies (TES) in areas
of varying malaria transmission intensities as per the World Health Organization (WHO) …
of varying malaria transmission intensities as per the World Health Organization (WHO) …
Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in mainland Tanzania, 2019
…, E Kamugisha, M Ahmed, MK Mahende… - Malaria journal, 2024 - Springer
Background Artemisinin-based combination therapy (ACT) has been a major contributor to
the substantial reductions in global malaria morbidity and mortality over the last decade. In …
the substantial reductions in global malaria morbidity and mortality over the last decade. In …